ZBH - ZIMMER BIOMET HOLDINGS, INC.
Close
106.8
-0.165 -0.154%
Share volume: 13,995
Last Updated: Fri 27 Dec 2024 08:30:16 PM CET
Surgical and Medical Instrument Manufacturing :
-0.06%
PREVIOUS CLOSE
CHG
CHG%
$106.96
-0.17
-0.15%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-02 | 2022-11-02 | 2023-02-24 | 2023-05-02 | 2023-08-01 | 2023-11-07 | 2024-02-23 | 2024-05-02 | |
| Assets | |||||||||
| Total Assets | 21.453 B | 21.333 B | 21.066 B | 21.244 B | 21.294 B | 21.217 B | 21.497 B | 21.452 B | |
| Current Assets | 4.463 B | 4.534 B | 4.427 B | 4.412 B | 4.388 B | 4.372 B | 4.610 B | 4.631 B | |
| Inventories | 2.123 B | 2.129 B | 2.147 B | 2.241 B | 2.276 B | 2.323 B | 2.385 B | 2.388 B | |
| Other Current Assets | 671.700 M | 581.900 M | 522.900 M | 459.500 M | 425.100 M | 415.800 M | 366.100 M | 403.800 M | |
| Short Term Investments | 671.700 M | 581.900 M | 522.900 M | 459.500 M | 425.100 M | 415.800 M | 366.100 M | 403.800 M | |
| Total Receivables | 1.282 B | 1.279 B | 1.382 B | 1.381 B | 1.367 B | 1.341 B | 1.442 B | 1.446 B | |
| Current Cash | 386.400 M | 545.400 M | 375.700 M | 330.200 M | 319.800 M | 292.100 M | 415.800 M | 393.000 M | |
| Total Non-current Assets | 16.990 B | 16.799 B | 16.639 B | 16.832 B | 16.906 B | 16.845 B | 16.887 B | 16.821 B | |
| Property Plant Equipment | 1.797 B | 1.802 B | 1.873 B | 1.906 B | 1.975 B | 2.032 B | 2.060 B | 2.091 B | |
| Other Assets | 1.020 B | 1.062 B | 1.122 B | 1.119 B | 1.160 B | 1.211 B | 1.152 B | 1.204 B | |
| Intangible Assets | 5.304 B | 5.137 B | 5.064 B | 5.072 B | 5.028 B | 4.892 B | 4.856 B | 4.734 B | |
| Goodwill | 8.869 B | 8.799 B | 8.580 B | 8.735 B | 8.744 B | 8.710 B | 8.819 B | 8.792 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 21.453 B | 21.333 B | 21.066 B | 21.244 B | 21.294 B | 21.217 B | 21.497 B | 21.452 B | |
| Total liabilities | 9.334 B | 9.089 B | 9.046 B | 9.093 B | 8.923 B | 8.707 B | 9.017 B | 8.854 B | |
| Total current liabilities | 2.464 B | 2.296 B | 2.358 B | 2.336 B | 2.234 B | 2.072 B | 2.858 B | 2.797 B | |
| Accounts Payable | 307.100 M | 333.900 M | 354.100 M | 397.100 M | 354.600 M | 319.700 M | 410.600 M | 370.300 M | |
| Other liabilities | 1.166 B | 1.190 B | 1.054 B | 1.061 B | 1.018 B | 1.035 B | 925.800 M | 852.800 M | |
| Current long term debt | 851.900 M | 659.100 M | 544.300 M | 585.000 M | 520.000 M | 355.000 M | 900.000 M | 970.000 M | |
| Long term debt | 5.172 B | 5.055 B | 5.152 B | 5.205 B | 5.189 B | 5.127 B | 4.868 B | 4.826 B | |
| Other liabilities | 1.166 B | 1.190 B | 1.054 B | 1.061 B | 1.018 B | 1.035 B | 925.800 M | 852.800 M | |
| Minority interest | 6.200 M | 6.400 M | 6.700 M | 6.900 M | 7.100 M | 7.200 M | 7.700 M | 8.100 M | |
| Total Shareholder equity | 12.118 B | 12.245 B | 12.020 B | 12.151 B | 12.372 B | 12.511 B | 12.481 B | 12.598 B | |
| Common stock | 209.600 M | 209.800 M | 209.800 M | 209.400 M | 208.600 M | 208.900 M | 207.900 M | 205.200 M | |
| Retained earnings | 9.607 B | 9.740 B | 9.559 B | 9.742 B | 9.902 B | 10.015 B | 10.385 B | 10.509 B |